Pathogenic LRRK2 Mutations Do Not Alter Gene Expression in Cell Model Systems or Human Brain Tissue

• Michael J. Devine ,

  Contributed equally to this work with: Michael J. Devine, Alice Kaganovich

  Affiliation Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom

  ⨯
• Alice Kaganovich ,

  Contributed equally to this work with: Michael J. Devine, Alice Kaganovich

  Affiliation Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Mina Ryten,

  Affiliation Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom

  ⨯
• Adamantios Mamais,

  Affiliations Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom, Rita Lila Weston Institute and Queen Square Brain Bank, UCL Institute of Neurology, London, United Kingdom

  ⨯
• Daniah Trabzuni,

  Affiliation Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom

  ⨯
• Claudia Manzoni,

  Affiliation Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom

  ⨯
• Philip McGoldrick,

  Affiliation MRC Centre for Neuromuscular Disease, UCL Institute of Neurology, London, United Kingdom

  ⨯
• Diane Chan,

  Affiliation Department of Pharmacology, Boston University School of Medicine, Boston, Massachusetts, United States of America

  ⨯
• Allissa Dillman,

  Affiliation Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Julia Zerle,

  Affiliation Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom

  ⨯
• Susannah Horan,

  Affiliation Department of Clinical Neuroscience, UCL Institute of Neurology, London, United Kingdom

  ⨯
• Jan-Willem Taanman,

  Affiliation Department of Clinical Neuroscience, UCL Institute of Neurology, London, United Kingdom

  ⨯
• John Hardy,

  Affiliation Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom

  ⨯
• Jose-Felix Marti-Masso,

  Affiliation Hospital Donastia, San Sebastian, Spain

  ⨯
• Daniel Healey,

  Current address: Beaumont Hospital, Dublin, Co. Dublin, Ireland,

  Affiliation Department of Clinical Neuroscience, UCL Institute of Neurology, London, United Kingdom

  ⨯
• Anthony H. Schapira,

  Affiliation Department of Clinical Neuroscience, UCL Institute of Neurology, London, United Kingdom

  ⨯
• Benjamin Wolozin,

  Affiliation Department of Pharmacology, Boston University School of Medicine, Boston, Massachusetts, United States of America

  ⨯
• Rina Bandopadhyay,

  Affiliations Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom, Rita Lila Weston Institute and Queen Square Brain Bank, UCL Institute of Neurology, London, United Kingdom

  ⨯
• Mark R. Cookson,

  Affiliation Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Marcel P. van der Brug ,

  * E-mail: mvanderb@scripps.edu (MPvdB); p.lewis@ion.ucl.ac.uk (PAL)

  Current address: Genentech Inc., South San Francisco, California, United States of America

  Affiliation The Scripps Research Institute, Jupiter, Florida, United States of America

  ⨯
•  [ ... ],
• Patrick A. Lewis

  * E-mail: mvanderb@scripps.edu (MPvdB); p.lewis@ion.ucl.ac.uk (PAL)

  Affiliation Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom

  ⨯
• [ view all ]
• [ view less ]